Erez Raphael - 18 May 2022 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Role: Chief Executive Officer, Director
Signature: /s/ Erez Raphael
Issuer symbol: DRIO
Transactions as of: 18 May 2022
Net transactions value: $0
Form type: 4
Filing time: 20 May 2022, 17:02:08 UTC
Previous filing: 09 Nov 2021
Next filing: 18 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DRIO	Common Stock	Award	$0	+275,000	+33%	$0.000000	1,113,259	18 May 2022	Direct	F1
holding	DRIO	Common Stock						37,876	18 May 2022	By Dicilyon Consulting and Investment Ltd.	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter.
F2	The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.

Content

The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter.

The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.